Cited by 861Multiple Sclerosis Research StudiesPolyomavirus and related diseasesPeripheral Neuropathies and Disorders

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

Open access

Brex, Peter A., Ciccarelli, Olga, O'Riordan, Jonathon I., Sailer, Michael, Thompson, Alan J., Miller, David H.·2002·New England Journal of Medicine

DOI 10.1056/nejmoa011341

Open this paper in CoChat — free account Open PDF

Abstract

Background In patients with isolated syndromes that are clinically suggestive of multiple sclerosis, such as optic neuritis or brain-stem or spinal cord syndromes, the presence of lesions as determined by T2-weighted magnetic resonance imaging (MRI) of the brain increases the likelihood that multiple sclerosis will develop. We sought to determine the relation between early lesion volume, changes in volume, and long-term disability. Methods Seventy-one patients in a serial MRI study of patients with isolated syndromes were reassessed after a mean of 14.1 years. Disability was measured with the use of Kurtzke's Expanded Disability Status Scale (EDSS; possible range, 0 to 10, with a higher score indicating a greater degree of disability). Results Clinically definite multiple sclerosis developed in 44 of the 50 patients (88 percent) with abnormal results on MRI at presentation and in 4 of 21 patients (19 percent) with normal results on MRI. The median EDSS score at follow-up for those with multiple sclerosis was 3.25 (range, 0 to 10); 31 percent had an EDSS score of 6 or more (including three patients whose deaths were due to multiple sclerosis). The EDSS score at 14 years correlated moderately with lesion volume on MRI at 5 years (r=0.60) and with the increase in lesion volume over the first 5 years (r=0.61). Conclusions In patients who first present with isolated syndromes suggestive of multiple sclerosis, the increases in the volume of the lesions seen on magnetic resonance im…

Integrity signals

Registry

Crossref · 10.1056/nejmoa011341

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Practical Statistics for Medical Research.
Walter, S., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,666
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Self-citation
Tests for comparing elements of a correlation matrix
Steiger, J. H. (1980) · Psychological Bulletin · doi:10.1037/0033-2909.87.2.245 · Cited by 4,621
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Defining the clinical course of multiple sclerosis
LUBLIN, F. D., & Reingold, S. C. (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,762

Flagged first, then by citations

Show all 42 references

Research works printed but not linked: 2

Molyneux PD, 1998, AJNR Am J Neuroradiol, 19, 1715
Paty DW, 1993, Neurology, 43, 6627

Sorted by citations

Items 201–300 of 858

Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters
Minneboo, A., Jasperse, B., Barkhof, F., Uitdehaag, B. M. J., Knol, D. L., de Groot, V., Polman, C. H., & Castelijns, J. A. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.124123 · Cited by 61
Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis
Nolan, R. C., Galetta, S. L., Frohman, T. C., Frohman, E. M., Calabresi, P. A., Castrillo‐Viguera, C., Cadavid, D., & Balcer, L. J. (2018) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000629 · Cited by 63
Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event
Rauer, S. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.077784 · Cited by 61
Role of MRI in diagnosis and treatment of multiple sclerosis
Sahraian, M. A., & Eshaghi, A. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2010.03.022 · Cited by 61
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis
Giorgio, A., Stromillo, M. L., Bartolozzi, M. L., Rossi, F., Battaglini, M., Leucio, A. D., Guidi, L., Maritato, P., Portaccio, E., Sormani, M. P., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513494490 · Cited by 60
Functional pathway-defined MRI diffusion measures reveal increased transverse diffusivity of water in multiple sclerosis
Lowe, M. J., Horenstein, C. I., Hirsch, J. G., Marrie, R. A., Stone, L. A., Bhattacharyya, P. K., Gass, A., & Phillips, M. D. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.04.208 · Cited by 60
Cerebral Atrophy Measurement in Clinically Isolated Syndromes and Relapsing Remitting Multiple Sclerosis: A Comparison of Registration‐Based Methods
Anderson, V., Fernando, K., Davies, G., Rashid, W., Frost, C., Fox, N. C., & Miller, D. H. (2007) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2006.00081.x · Cited by 59
Self-citation
Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria
Nielsen, J. M., Korteweg, T., Barkhof, F., Uitdehaag, B. M. J., & Polman, C. H. (2005) · Annals of Neurology · doi:10.1002/ana.20632 · Cited by 72
THE NEURO-OPHTHALMOLOGY OF MULTIPLE SCLEROSIS
Frohman, T. C., Graves, J. S., Balcer, L. J., Galetta, S. L., & Frohman, E. M. (2010) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000389938.07532.67 · Cited by 59
Cerebellar cortical atrophy in experimental autoimmune encephalomyelitis
MacKenzie-Graham, A., Tinsley, M. R., Shah, K. P., Aguilar, C., Strickland, L. V., Boline, J., Martin, M., Morales, L., Shattuck, D., Jacobs, R., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.05.006 · Cited by 59
Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy
Blamire, A. M., Cader, S., Lee, M., Palace, J. A., & Matthews, P. M. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21382 · Cited by 58
Cognitive functioning in multiple sclerosis.
Julian, L. (2011) · Neurologic clinics · doi:10.1016/j.ncl.2010.12.003 · Cited by 31
High sensitivity measurement of CRP and disease progression in multiple sclerosis
Soilu‐Hänninen, M., Koskinen, J. O., Laaksonen, M., Hänninen, A. L. M., Lilius, E. ‐., & Waris, M. E. (2005) · Neurology · doi:10.1212/01.wnl.0000167129.90918.f5 · Cited by 58
Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases
Bruna, J., Martínez‐Yélamos, S., Martı́nez-Yélamos, A., Rubio, F., & Arbizu, T. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1260oa · Cited by 58
Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis
Pittock, S. J., Weinshenker, B. G., Noseworthy, J. H., Lucchinetti, C. F., Keegan, M., Wingerchuk, D. M., Carter, J., Shuster, E. A., & Rodriguez, M. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.611 · Cited by 58
Prediction of long-term disability in multiple sclerosis
Schlaeger, R., D’Souza, M., Schindler, C., Grize, L., Dellas, S., Radue, E. W., Kappos, L., & Fuhr, P. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511416836 · Cited by 57
The 14-3-3 protein in multiple sclerosis: a marker of disease severity
Colucci, M. E. W., Roccatagliata, L., Capello, E., Narciso, E., Latronico, N., Tabaton, M., & Mancardi, G. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1089oa · Cited by 57
Identifying and treating patients with suboptimal responses
Cohen, B. A., Khan, O., Jeffery, D., Bashir, K., Rizvi, S., Fox, E., Agius, M. A., Bashir, R., Collins, T. E., Herndon, R. M., et al. (2004) · Neurology · doi:10.1212/wnl.63.12_suppl_6.s33 · Cited by 57
Utility of Disease-Specific Measures and Clinical Balance Tests in Prediction of Falls in Persons With Multiple Sclerosis
Dibble, L. E., Lopez‐Lennon, C., Lake, W., Hoffmeister, C., & Gappmaier, E. (2013) · Neurology Report · doi:10.1097/npt.0b013e3182a18460 · Cited by 57
Quantitative Cervical Spinal Cord 3T Proton MR Spectroscopy in Multiple Sclerosis
Marliani, A. F., Clementi, V., Riccioli, L. A., Agati, R., Carpenzano, M., Salvi, F., & Leonardi, M. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1738 · Cited by 57
Autoimmune myelopathies
Flanagan, E. P. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00019-0 · Cited by 57
Phases and Phenotypes of Multiple Sclerosis
Kantarci, O. H. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000737 · Cited by 62
Multiple Sclerosis Cerebrospinal Fluid Biomarkers
Giovannoni, G. (2006) · Disease Markers · doi:10.1155/2006/509476 · Cited by 57
Predicting clinical progression in multiple sclerosis after 6 and 12 years
Dekker, I., Eijlers, A. J. C., Popescu, V., Balk, L. J., Vrenken, H., Wattjes, M. P., Uitdehaag, B. M. J., Killestein, J., Geurts, J. J. G., Barkhof, F., et al. (2019) · European Journal of Neurology · doi:10.1111/ene.13904 · Cited by 56
Development of biomarkers for multiple sclerosis as a neurodegenerative disorder
Ziemann, U., Wahl, M., Hattingen, E., & Tumani, H. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.007 · Cited by 55
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution
Rovaris, M., Gambini, A., Gallo, A., Falini, A., Ghezzi, A., Benedetti, B., Sormani, M., Martinelli, V., Comi, G., & Filippi, M. (2005) · Neurology · doi:10.1212/01.wnl.0000184493.06254.a6 · Cited by 60
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF
Kühle, J., Lindberg, R. L. P., Regeniter, A., Mehling, M., Hoffmann, F., Reindl, M., Berger, T., Radue, E. W., Leppert, D., & Kappos, L. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0299-4 · Cited by 55
Updates on Clinically Isolated Syndrome and Diagnostic Criteria for Multiple Sclerosis
Marcus, J. F., & Waubant, E. L. (2012) · The Neurohospitalist · doi:10.1177/1941874412457183 · Cited by 61
Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial
Rovaris, M., Comi, G., Rocca, M. A., Valsasina, P., Ladkani, D., Pieri, E., Weiss, S., Shifroni, G., Wolinsky, J. S., Filippi, M., et al. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070704 · Cited by 54
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials
Barkhof, F., Held, U., Simon, J. H., Däumer, M., Fazekas, F., Filippi, M., Frank, J. A., Kappos, L., Li, D. K. B., Menzler, S., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000183149.87975.32 · Cited by 54
Self-citation
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis
Cameron, E. M., Spencer, S. M., Lazarini, J., Harp, C. T., Ward, E. S., Burgoon, M. P., Owens, G. P., Racke, M. K., Bennett, J. L., Frohman, E. M., et al. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.05.014 · Cited by 52
Approach to acute or subacute myelopathy
Schmalstieg, W. F., & Weinshenker, B. G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fb3638 · Cited by 52
Deep learning with diffusion basis spectrum imaging for classification of multiple sclerosis lesions
Ye, Z., George, A., Wu, A. T., Niu, X., Lin, J. Y.-Y., Adusumilli, G., Naismith, R. T., Cross, A. H., Sun, P., & Song, S. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51037 · Cited by 55
Rate of Brain Atrophy in Benign vs Early Multiple Sclerosis
Gauthier, S. A., Berger, A. M., Liptak, Z., Duan, Y., Egorova, S., Buckle, G. J., Glanz, B. I., Khoury, S. J., Bakshi, R., Weiner, H. L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.567 · Cited by 51
Long-term Follow-up of Acute Partial Transverse Myelitis
Bourre, B. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.949 · Cited by 50
Predictors of disability worsening in clinically isolated syndrome
Jokubaitis, V., Spelman, T. D., Kalinčík, T., Izquierdo, G., Grand’Maison, F., Duquette, P., Girard, M., Lugaresi, A., Grammond, P., Hupperts, R., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.187 · Cited by 49
A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting
Karussis, D. M., Biermann, L., Bohlega, S., Бойко, А. Н., Chofflon, M., Fazekas, F., Freedman, M. S., Gebeily, S., Gouider, R., Havrdová, E., et al. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01147.x · Cited by 50
Predicting short-term disability in multiple sclerosis
Gauthier, S. A., Mandel, M., Guttmann, C. R. G., Glanz, B. I., Khoury, S. J., Betensky, R. A., & Weiner, H. L. (2007) · Neurology · doi:10.1212/01.wnl.0000264890.97479.b1 · Cited by 50
Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives
Bar-Zohar, D., Agosta, F., Goldstaub, D., & Filippi, M. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507088102 · Cited by 50
High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis
Wattjes, M. P., Harzheim, M., Lutterbey, G. G., Bogdanow, M., Schild, H. H., & Träber, F. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0666-9 · Cited by 49
Molecular mechanism underlying the impact of vitamin D on disease activity of MS
Munger, K. L., Köchert, K., Simon, K. C., Kappos, L., Polman, C. H., Freedman, M. S., Hartung, H. P., Miller, D. H., Montalbán, X., Edan, G., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.91 · Cited by 49
Self-citation
Severe, Highly Active, or Aggressive Multiple Sclerosis
Freedman, M. S., & Rush, C. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000331 · Cited by 49
Treatment and treatment trials in multiple sclerosis
Kieseier, B. C., Wiendl, H., Hemmer, B., & Hartung, H. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3281568b80 · Cited by 50
Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage
Linker, R. A., Brechlin, P., Jesse, S., Steinacker, P., Lee, D. H., Asif, A. R., Jahn, O., Tumani, H., Gold, R., & Otto, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007624 · Cited by 49
MR Imaging Intensity Modeling of Damage and Repair In Multiple Sclerosis: Relationship of Short-Term Lesion Recovery to Progression and Disability
Meier, D., Weiner, H. L., & Guttmann, C. R. G. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0701 · Cited by 49
Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes—A 2-year MR Imaging Study
Rocca, M. A., Preziosa, P., Mesaroš, Š., Pagani, E., Dackovic, J. R., Stošić-Opinćal, T., Drulovic, J. S., & Filippi, M. (2015) · Radiology · doi:10.1148/radiol.2015150532 · Cited by 48
Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis
Fisniku, L., Altmann, D. R., Cercignani, M., Tozer, D. J., Chard, D., Jackson, J., Miszkiel, K., Schmierer, K., Thompson, A. J., & Miller, D. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509103715 · Cited by 47
Self-citation
Magnetic Resonance Imaging Effects of Interferon Beta-1b in the BENEFIT Study
Barkhof, F., Polman, C. H., Radue, E. W., Kappos, L., Freedman, M. S., Edan, G., Hartung, H., Miller, D. H., Montalbán, X., Poppe, P. A., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.9.1292 · Cited by 48
Self-citation
Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta
Comı, G. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.06.007 · Cited by 48
Depression and Cognitive Impairment in Disability‐Free Early Multiple Sclerosis
Haase, C. G., Tinnefeld, M., Lienemann, M., Ganz, R. E., & Faustmann, P. M. (2003) · Behavioural Neurology · doi:10.1155/2003/843760 · Cited by 48
Pharmacological Treatment of Early Multiple Sclerosis
Stüve, O., Bennett, J. L., Hemmer, B., Wiendl, H., Racke, M. K., Bar‐Or, A., Hu, W., Zivadinov, R., Weber, M. S., Zamvil, S. S., et al. (2008) · Drugs · doi:10.2165/00003495-200868010-00005 · Cited by 48
Diffusion tensor imaging of the optic radiations after optic neuritis
Kolbe, S., Bajraszewski, C., Chapman, C., Nguyen, T., Mitchell, P. J., Paine, M., Butzkueven, H., Johnston, L. A., Kilpatrick, T. J., & Egan, G. F. (2011) · Human Brain Mapping · doi:10.1002/hbm.21343 · Cited by 48
MRI only conversion to multiple sclerosis following a clinically isolated syndrome
Chard, D. T., Dalton, C. M., Swanton, J., Fisniku, L. K., Miszkiel, K. A., Thompson, A. J., Plant, G. T., & Miller, D. H. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.208660 · Cited by 47
Self-citation
Progressive Forms of Multiple Sclerosis
Zeydan, B., & Kantarci, O. H. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.08.006 · Cited by 52
Ventricular enlargement in MS
Dalton, C., Miszkiel, K., O’Connor, P., Plant, G., Rice, G. P., & Miller, D. (2006) · Neurology · doi:10.1212/01.wnl.0000201183.87175.9f · Cited by 23
Self-citation
A population-based case–control study on viral infections and vaccinations and subsequent multiple sclerosis risk
Ahlgren, C., Torén, K., Odén, A., & Andersen, O. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9367-2 · Cited by 47
Natural history of multiple sclerosis: implications for counselling and therapy
Confavreux, C., & Vukusic, S. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200206000-00006 · Cited by 49
The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis
Bakshi, R., Hutton, G. J., Miller, J. R., & Radue, E. (2004) · Neurology · doi:10.1212/wnl.63.11_suppl_5.s3 · Cited by 44
Personalized Medicine in Multiple Sclerosis
Giovannoni, G. (2017) · Neurodegenerative Disease Management · doi:10.2217/nmt-2017-0035 · Cited by 46
Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations
Ahlgren, C., Odén, A., Torén, K., & Andersen, O. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01131.x · Cited by 45
Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model
Pulli, B., Buré, L., Wojtkiewicz, G. R., Iwamoto, Y., Ali, M. Y. J., Li, D., Schob, S., Hsieh, K. L., Jacobs, A. H., & Chen, J. W. (2014) · Radiology · doi:10.1148/radiol.14141495 · Cited by 48
Normal-appearing grey and white matter T 1 abnormality in early relapsing–remitting multiple sclerosis: a longitudinal study
Davies, G., Hadjiprocopis, A., Altmann, D. R., Chard, D., Griffin, C., Rashid, W., Parker, G. J. M., Tofts, P. S., Kapoor, R., Thompson, A. J., et al. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070726 · Cited by 44
Self-citation
CD4 T cell activation and disease activity at onset of multiple sclerosis
Jensen, J. S., Langkilde, A. R., Fenst, C., Nicolaisen, M. S., Roed, H., Christiansen, M., & Sellebjerg, F. T. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.12.019 · Cited by 46
Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis
Young, P. J., Lederer, C., Eder, K., Däumer, M., Neiß, A., Polman, C. H., & Kappos, L. (2006) · Neurology · doi:10.1212/01.wnl.0000234064.17156.03 · Cited by 46
Comparison of multiple tractography methods for reconstruction of the retinogeniculate visual pathway using diffusion MRI
He, J., Zhang, F., Xie, G., Yao, S., Feng, Y., Bastos, D. C. A., Yogesh Rathi, A., Makris, N., Kikinis, R., Golby, A. J., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25472 · Cited by 43
Interferon-β-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis
Graber, J. J., Zhan, M., Ford, D., Kursch, F., Francis, G., Bever, C. T., PANITCH, H. S., Calabresi, P. A., & Dhib-Jalbut, S. S. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.11.017 · Cited by 45
The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: A post hoc analysis of data from CHAMPS
O'Connor, P. W. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80339-9 · Cited by 45
MS: is it one disease?
Barnett, M. H., Parratt, J. D. E., Pollard, J. D., & Prineas, J. W. (2009) · PubMed · Cited by 44
Diffusion abnormality maps in demyelinating disease: Correlations with clinical scores
Onu, M., Roceanu, A. M., Sboto‐Frankenstein, U., Bendic, R., Tarta, E., Preoteasa, F., & Băjenaru, O. (2012) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.12.014 · Cited by 47
Bringing CLARITY to gray matter atrophy
Spence, R. D., Kurth, F., Itoh, N., Mongerson, C. R., Wailes, S. H., Peng, M. S., & MacKenzie‐Graham, A. J. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.07.017 · Cited by 44
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials
Derfuss, T. J., Ontaneda, D., Nicholas, J. A., Meng, X., & Hawker, K. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.05.015 · Cited by 44
Early treatment of multiple sclerosis to prevent neurologic damage
Coyle, P. K. (2008) · Neurology · doi:10.1212/wnl.0b013e31818f3d6f · Cited by 44
High risk of MS in Iranian immigrants in Gothenburg, Sweden
Ahlgren, C., Lycke, J., Odén, A., & Andersen, O. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510376777 · Cited by 43
Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis
Wattjes, M. P., Harzheim, M., Lutterbey, G. G., Bogdanow, M., Schmidt, S., Schild, H. H., & Träber, F. (2007) · Neuroradiology · doi:10.1007/s00234-007-0325-y · Cited by 43
Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis.
Rovaris, M., Comi, G., Ladkani, D., Wolinsky, J. S., & Filippi, M. (2003) · PubMed Central · Cited by 43
Assessment of Outcome Predictors in First-Episode Acute Myelitis
Gajofatto, A., Monaco, S., Fiorini, M., Zanusso, G., Vedovello, M., Rossi, F., Turatti, M., & Benedetti, M. D. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.107 · Cited by 42
Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity
Schulze‐Topphoff, U., Casazza, S., Varrin‐Doyer, M., Pekarek, K. L., Sobel, R. A., Hauser, S. L., Oksenberg, J. R., Zamvil, S. S., & Baranzini, S. E. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121611 · Cited by 43
Consenso para el tratamiento de la esclerosis múltiple 2016. Sociedad Española de Neurología
Merino, A. G., Ara, J. R., Fernández, Ó., Pascual, L. L., Torres, E. M., & Zarrantz, A. R.-A. (2016) · Neurología · doi:10.1016/j.nrl.2016.02.026 · Cited by 42
Imaging the optic nerve in multiple sclerosis
Rocca, M. A., Hickman, S. J., Bø, L., Agosta, F., Miller, D. H., Comı, G., & Filippi, M. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1213oa · Cited by 42
Self-citation
Time-Series Modeling of Multiple Sclerosis Disease Activity: A Promising Window on Disease Progression and Repair Potential?
Meier, D., Weiner, H. L., & Guttmann, C. R. G. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.05.008 · Cited by 39
Natural History of Multiple Sclerosis: Long-Term Prognostic Factors
Renoux, C. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.01.006 · Cited by 41
Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course.
Bartolomei, I., Salvi, F., Galeotti, R., Salviato, E., Alcanterini, M., Menegatti, E., Mascalchi, M., & Zamboni, P. (2010) · PubMed · Cited by 41
MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry
Bendfeldt, K., Taschler, B., Gaetano, L., Madoerin, P., Küster, P., Mueller‐Lenke, N., Amann, M., Vrenken, H., Wottschel, V., Barkhof, F., et al. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9942-9 · Cited by 41
Contemporary Management of the Neurogenic Bladder for Multiple Sclerosis Patients
Stoffel, J. T. (2010) · Urologic Clinics of North America · doi:10.1016/j.ucl.2010.06.003 · Cited by 41
Rationale for early intervention with immunomodulatory treatments
Tintoré, M. (2008) · Journal of Neurology · doi:10.1007/s00415-008-1006-4 · Cited by 41
Optic neuritis and risk of MS: Differential diagnosis and management
Osborne, B., & Volpe, N. J. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76a.07268 · Cited by 40
Time course of clinical and neuroradiological effects of delayed‐release dimethyl fumarate in multiple sclerosis
Kappos, L., Giovannoni, G., Gold, R., Phillips, J. T., Arnold, D. L., Hotermans, C., Zhang, A., Viglietta, V., Fox, R. J., & the DEFINE and CONFIRM study investigators (2015) · European Journal of Neurology · doi:10.1111/ene.12624 · Cited by 40
Generative diffeomorphic modelling of large MRI data sets for probabilistic template construction
Blaiotta, C., Freund, P., Cardoso, M. J., & Ashburner, J. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.10.060 · Cited by 39
Predictive Values of Location and Volumetric MRI Injury Patterns for Neurodevelopmental Outcomes in Hypoxic-Ischemic Encephalopathy Neonates
Chang, P., Chow, D. S., Alber, A., Lin, Y., & Youn, Y. (2020) · Brain Sciences · doi:10.3390/brainsci10120991 · Cited by 40
Multiple sclerosis – novel insights and new therapeutic strategies
Kieseier, B. C., Hemmer, B., & Hartung, H. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169735.60922.fb · Cited by 39
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis
Branger, P., Parienti, J., Sormani, M. P., & Defer, G. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149685 · Cited by 40
An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS
Rovaris, M., Gallo, A., Riva, R., Ghezzi, A., Bozzali, M., Benedetti, B., Martinelli, V., Falini, A., Comi, G., & Filippi, M. (2004) · Neurology · doi:10.1212/01.wnl.0000133209.76642.ef · Cited by 40
Neurodegeneration in autoimmune demyelination: Recent mechanistic insights reveal novel therapeutic targets
Aktaş, O., Waiczies, S., & Zipp, F. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.026 · Cited by 40
Acute Inflammatory Demyelinating Optic Neuritis
Zeid, N. E. A., & Bhatti, M. T. (2008) · The Neurologist · doi:10.1097/nrl.0b013e31816f27fe · Cited by 39
Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies
Gold, R., Giovannoni, G., Phillips, J. T., Fox, R. J., Zhang, A., & Marantz, J. L. (2016) · Neurology and Therapy · doi:10.1007/s40120-016-0042-8 · Cited by 40
Association between MRI parameters and the MS severity scale: a 12 year follow-up study
Minneboo, A., Uitdehaag, B. M. J., Jongen, P. J. H., Vrenken, H., Knol, D., van Walderveen, M., Polman, C. H., Castelijns, J. A., & Barkhof, F. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509102617 · Cited by 39
Chemical exchange saturation transfer of the cervical spinal cord at 7 T
Dula, A. N., Pawate, S., Dethrage, L. M., Conrad, B. N., Dewey, B. E., Barry, R. L., & Smith, S. A. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3581 · Cited by 39
An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions
Dworkin, J. D., Linn, K. A., Oğuz, İ., Fleishman, G. M., Bakshi, R., Nair, G., Calabresi, P. A., Henry, R. G., Oh, J., Papinutto, N., et al. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5556 · Cited by 39
Optic neuritis in multiple sclerosis
Chan, J. W. (2002) · Ocular Immunology and Inflammation · doi:10.1076/ocii.10.3.161.15603 · Cited by 39
Gait and balance deterioration over a 12-month period in multiple sclerosis patients with EDSS scores ≤ 3.0
Galea, M. P., Lizama, L. E. C., Butzkueven, H., & Kilpatrick, T. J. (2017) · Neurorehabilitation · doi:10.3233/nre-161413 · Cited by 38

Authors: Brex, P. A., Ciccarelli, O., O'Riordan, J. I., Sailer, M., Thompson, A. J., & Miller, D. H.
Affiliations: National Hospital for Neurology and Neurosurgery (GB)
Otto-von-Guericke-Universität Magdeburg (DE)
ORCID: Ciccarelli, Olga
Sailer, Michael
Thompson, Alan J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2002-01-17
Volume: 346
Issue: 3
Pages: 158-164
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa011341
OpenAlex: W1966515383
Cited by: 861
References: 42
Citations by year: 2026: 5 · 2025: 10 · 2024: 11 · 2023: 9 · 2022: 14 · 2021: 20 · 2020: 14 · 2019: 23 · 2018: 27 · 2017: 33 · 2016: 30 · 2015: 32 · 2014: 44 · 2013: 34 · 2012: 40
FWCI: 36.73
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Multiple Sclerosis Society
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Keywords: multiple sclerosis, long-term disability, Expanded Disability Status Scale, optic neuritis, spinal cord syndromes, T2-weighted MRI, disease-modifying therapy, disease progression
MeSH terms: Adolescent, Adult, Brain, Brain Diseases, Brain Stem, Disability Evaluation, Female, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Optic Neuritis, Spinal Cord Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks